HemOnc Today


The following articles appeared in the print edition of HEMONC TODAY.

Table of Contents

Drug costs, poverty, inequity and loss

Derek Raghavan, MD, PhD

FDA approvals

FDA approves Velcade regimen for treatment-naive mantle cell lymphoma

FDA News

FDA grants priority review to palbociclib for advanced breast cancer

FDA grants ‘breakthrough’ designation for ALK-positive NSCLC therapy

FDA grants fast track designation to NKTT120 for sickle cell disease

FDA grants priority review to blinatumomab for ALL


Guideline strongly recommends hydroxyurea, transfusion therapy for sickle cell disease

In the Journals

Lung cancer screening abnormalities prompted smoking cessation

Lifetime cancer risk from imaging radiation low in most pediatric heart patients

Fecal immunochemical tests detected most colorectal cancers

TH-302 demonstrates encouraging activity in soft tissue sarcoma

Current tobacco use linked to oral HPV-16 infection

Novel ALK inhibitor effective for crizotinib-resistant NSCLC

One in four patients with head, neck cancers do not receive guideline-directed adjuvant therapy

Researchers establish prevalence of uterine cancer at time of hysterectomy with morcellation

Smoking habits persisted among cancer survivors

Age-restricted PSA screening could reduce preventable deaths, overdiagnosis

Combination regimen safe, effective in treatment-naive myeloma

Comorbidities increased risk for death from primary myelofibrosis

Calcium, magnesium failed to reduce oxaliplatin-induced neurotoxicity

Eclampsia, acute systemic infection increased risk for postpartum VTE

IBD showed link with cervical neoplasia

Increased CTCs after chemotherapy associated with worse prognosis in metastatic breast cancer

Blistering sunburns in adolescence linked with 80% higher risk for melanoma

Diabetics’ elevated risk for pancreatic cancer persisted long after diagnosis

Institution Notes

Meridian appoints medical director for thoracic oncology

Oncology Nursing Society appoints new CEO

Mount Sinai names vice chairman of urology

ASCO bestows Bonadonna Award

Center names division head

Levine Cancer Institute appoints chief of breast medical oncology

Meeting News Coverage

Single-fraction radiation effective for bone metastases

Parental status influenced cancer care decisions

Contralateral mastectomy did not improve survival in young women

Bevacizumab plus second-line chemotherapy extended PFS in HER-2–negative breast cancer

Addition of triptorelin to chemotherapy preserved long-term ovarian function

Maintenance therapy with bevacizumab, capecitabine extended survival in HER-2–negative breast cancer

Cobimetinib plus vemurafenib extended PFS in BRAF V600-mutated metastatic melanoma

Social, demographic factors linked to mortality shortly after cancer surgery

Nivolumab superior to chemotherapy in metastatic melanoma